Cortisol release in the face of illness or stress is vital for survival. Relative adrenal insufficiency occurs when a patient's cortisol response is inadequate for the degree of illness or stress. Numerous studies have documented the existence of relative adrenal insufficiency in critically ill adults, and its association with increased morbidity and mortality. There is increasing evidence that relative adrenal insufficiency may be an etiology for hemodynamic instability and hypotension in the critically ill newborn, but compared with the adult population, there is still a paucity of data in this population. Randomized controlled trials are needed to evaluate the efficacy and safety of glucocorticoids for the treatment of cardiovascular insufficiency due to relative adrenal insufficiency in ill preterm and term newborn infants.
Introduction
Activation of the hypothalamic-pituitary-adrenal (HPA) axis and ultimate release of cortisol are critical in maintaining homeostasis in response to stress. Relative adrenal insufficiency occurs when the HPA axis produces insufficient cortisol for the degree of illness or stress. In some critically ill adult populations, relative adrenal insufficiency is prevalent, [1] [2] [3] [4] and is associated with increased morbidity and mortality. 2, 3, 5 Some studies of glucocorticoid treatment in critically ill adults have shown benefit, with faster reversal of shock and reduction in mortality. 3, [5] [6] [7] [8] Recently, increasing evidence supports the existence of relative adrenal insufficiency in ill newborns, but, similar to other ill populations, there remains no general consensus on which patients should be tested, which tests to use and how to interpret them, which patients should be treated or how they should be treated. 9 The following discussion is an overview of corticosteroid physiology, relative adrenal insufficiency in critically ill populations and evidence of its existence in newborn infants, with proposed underlying mechanisms, diagnostic criteria, consequences and recommendations for treatment.
Corticosteroid physiology
Cortisol is synthesized in the zona fasciculata of the adrenal cortex in response to stimulation from the adrenocorticotropic hormone (ACTH), which is synthesized in the pituitary. ACTH is released in response to the corticotropin-releasing hormone (CRH), which is produced in the hypothalamus. Numerous factors influence the release of CRH and ACTH, including neurological inputs from the normal diurnal rhythm and acute physiological stressors. Under basal conditions, cortisol in the plasma is primarily bound to cortisol-binding globulin or albumin; only about 5 to 10% is in the free, active form. Cortisol acts either by binding to glucocorticoid receptors on the cell surface and translocation to the nucleus, which ultimately results in the inhibition or activation of transcription of genes (genomic effects), or by direct interactions on the cell surface (non-genomic effects). 10 Cortisol has numerous biological effects, which include the maintenance of blood glucose levels, electrolyte balance, endothelial integrity, vascular permeability and the facilitation of renal free-water excretion. One of the most-studied roles of cortisol in periods of physical stress is suppression of the body's inflammatory responses.
11
The importance of the role of cortisol is exemplified in septic shock, in which there may be an overwhelming systemic inflammatory response with release of inflammatory mediators that can adversely affect heart contractility and endothelial integrity, leading to capillary leak syndrome. Release of cortisol or administration of glucocorticoids can attenuate this response and thus prevent cardiovascular collapse. 3, 5, 7 Cortisol is also proposed to play a vital role in maintaining hemodynamic stability through other mechanisms that are beyond the scope of this paper, including potentiating transmembrane calcium currents, increasing b-receptor sensitivity to catecholamines, reversing downregulation or inhibiting degradation of b-receptors, increasing the density of b-receptors or inhibiting nitric oxide synthase expression. 12 Indeed, the clinical feature that is most often linked with relative adrenal insufficiency in critically ill patients in the intensive care unit is hemodynamic instability and shock.
Relative adrenal insufficiency in critical illness
Both animal and human studies have shown that the absence of an appropriate cortisol response to stress leads to physiological instability, which can adversely affect the severity of illness, morbidity and mortality. Swingle et al. 13, 14 first showed that animals with adrenalectomies died from hypovolemic and laparotomy-induced shock, which could be prevented with glucocorticoids. Animals with adrenal insufficiency have hemodynamic instability before, during and after surgery, as well as increased mortality. 15 In humans, one of the earliest reports to show how essential HPA function was for survival in critical illness was from the University of Glasgow. Their post-surgical mortality rate for patients with multiple trauma rose unexpectedly from 22 to 29%, to 44% without any change in injury severity scores. 16 Analysis showed that this increase coincided with the introduction of etomidate, an anesthetic agent that induces partial adrenal insufficiency by inhibiting the 11b-hydroxylase enzyme required for cortisol synthesis. 16 Other possible etiologies for relative adrenal insufficiency in acute illness can arise from anywhere along the HPA axis, and can include effects of tumors, trauma, hemorrhage, cytokines, anesthetics, antibiotics or corticosteroid therapy on the hypothalamus, pituitary or adrenal gland. 9 Tissue resistance to glucocorticoids as a result of effects of cytokines, nitric oxide and HIV infection is also reported. 9 Relative adrenal insufficiency is clearly associated with cardiovascular dysfunction. However, because there are many causes of cardiovascular dysfunction in stressed patients, clinicians and researchers have searched for cortisol cutoff values that could be used to define relative adrenal insufficiency. Although these cutoff values have varied between studies, there is consensus that cortisol concentrations should be much higher during stress, and should correlate with the severity of illness. 17 In healthy, normal participants, cortisol values are generally <15 mcg per 100 ml, and baseline cortisol production is about 5 to 10 mg per m 2 per day. 17 In patients undergoing elective surgery, cortisol production can increase up to 150 mg per 24 h during major surgery, with the extent and duration of the rise correlating with the extent of surgery. 17 Patients with severe sepsis or multiple trauma have also been reported to have cortisol values threefold higher than normal, which remain elevated for a prolonged period of time. 17 In children with meningococcal sepsis, median admission cortisol values were found to 40 to 50 mcg per 100 ml. 18, 19 What constitutes an 'inappropriately' low cortisol for the degree of stress remains under debate, as is reflected in the large variability (3 to 56%) in the reported incidence of relative adrenal insufficiency in ill, intensive care unit patients. 4 In one of the first large reports, Finlay and McKee 20 found that 27% (36/133) of the intensive care unit patients had cortisol concentrations of <13 mcg per 100 ml (350 nmol l À1 ), and all of these patients died. In contrast, only 27% of patients with cortisol concentrations of >13 mcg per 100 ml died. These authors followed their observational study with a prospective, randomized trial of hydrocortisone supplementation. Of 18 intensive care unit patients with cortisol concentrations <13 mcg per 100 ml, 8 were randomized to hydrocortisone. Only one of these patients died, compared with 9 of the 10 placebo-treated patients. 21 Other investigators have also shown that hydrocortisone with or without fludrocortisone therapy results in clinical improvement in patients with hypotension. A multicenter, randomized controlled trial evaluating the effect of hydrocortisone replacement in 300 adults with septic shock showed that in the 229 patients who had an inadequate response to ACTH (defined as a rise in cortisol of <9 mcg per 100 ml, or <250 nmol l À1 ), treatment for 7 days with hydrocortisone and fludrocortisone resulted in earlier shock reversal (off vasopressors) and significantly improved 28-day survival compared with placebo (47 vs 37%, P ¼ 0.02). 5 Although other studies have confirmed the finding that glucocorticoid treatment in critically ill patients results in earlier shock reversal, 5-7 a recent study leaves the question of decreased mortality in dispute. The CORTICUS trial enrolled 499 patients, randomizing to 11 days of hydrocortisone or placebo. 8 This study showed faster shock reversal, but no difference in mortality. The study was stopped early because of slow recruitment, and there were several differences between this and the earlier study by Annane et al. The patients in this study were not as sick, with less severe shock and lower mortality in the placebo arms (35 vs 63%), the duration of hydrocortisone treatment was longer, and treatment was initiated later in the disease process.
As a result of these and other studies, a definition has been proposed for diagnosis of relative adrenal insufficiency in critically ill adults. A random cortisol value of <15 mcg per 100 ml (414 nmol l À1 ) is considered to be clear evidence of adrenal insufficiency. 9 A concentration between 15 and 34 mcg per 100 ml is indeterminate, and an ACTH stimulation test should be performed. A rise in serum cortisol of <9 mcg per 100 ml after ACTH stimulation is proposed to represent relative adrenal insufficiency.
Evidence for relative adrenal insufficiency in preterm newborn infants Rationale Very preterm neonates would be anticipated to be at increased risk for cortisol insufficiency in the face of acute illness and stress, because of immaturity of the adrenal gland. First, preterm newborns have limited 3b-hydroxysteroid dehydrogenase (HSD) and other enzymes necessary for the synthesis of cortisol. 22 The adrenal neocortex does not express 3b-HSD before 23 weeks gestation and generally does not synthesize cortisol de novo until about 30 weeks, before which the fetus uses progesterone from the placenta to bypass 3b-HSD and produce cortisol. Second, at this early gestation the fetal HPA axis is likely to be suppressed by the passive transmission of maternal cortisol across the placenta. The placenta contains 11b-HSD2, which metabolizes maternal cortisol to the biologically inactive cortisone. However, at early stages of gestation, there is little 11b-HSD2 activity, allowing maternal cortisol to cross the placenta, inhibiting the fetal HPA axis. Later in gestation, rising levels of 11b-HSD2 metabolize most of the maternal cortisol, releasing the fetal axis from suppression and resulting in increasing fetal cortisol production by the term infant. 23 In the extremely preterm infant, this suppression of the HPA axis by maternal cortisol likely contributes to the immaturity of the axis and possibly to relative adrenal insufficiency in the face of stress.
Clinical evidence
Two abstracts from 1989 and 1991 first described inadequate adrenal function in ill preterm newborns presenting with hypotension, oliguria and hyperkalemia. 24, 25 Subsequently, numerous studies have described lower cortisol concentrations and/or lower response to ACTH in critically ill preterm infants compared with well infants, in those receiving inotropic support compared with those not, and in those presenting with respiratory distress syndrome compared with those without. [26] [27] [28] [29] [30] In addition, several authors have reported lower cortisol responses to ACTH in infants who subsequently develop bronchopulmonary dysplasia. 28,31 -34 The possible relationship between adrenal insufficiency and cardiovascular instability is of particular interest, because if this is true, glucocorticoids may be a more appropriate therapy for hypotension than vasopressors. Several studies support such a link, showing that preterm infants receiving vasopressor support have lower basal and stimulated cortisol values. 26, 35 In addition, Arnold et al. 36 showed that cortisol production rate and secretory burst frequency correlated directly with mean arterial blood pressure in preterm infants. Supporting this finding, Yoder et al. 37 found that in extremely preterm baboons, the urinary cortisol excretion rate, a measure of cortisol production, was significantly lower in those baboons with poor cardiovascular function as measured by echocardiography.
The association of impaired adrenal function with hypotension and poor cardiovascular function is further supported by the positive response to glucocorticoids in both the baboon study 37 and in several studies of preterm infants. [38] [39] [40] [41] [42] [43] In the study by Yoder et al., 37 the baboons with low cortisol production and hypotension refractory to vasopressor and volume support were given hydrocortisone and responded with improvement of left ventricular function, blood pressure and metabolic acidosis. A recent study of cardiac function in human infants administered hydrocortisone specifically showed increased blood pressure and systemic vascular resistance, increased stroke volume and increased cardiac output with no change in cerebral or renal blood flow. 44 The two randomized trials of glucocorticoid therapy to treat hypotension in preterm infants showed improvement of blood pressure, decreased administration of vasopressors, decreased days on vasopressors and decreased use of volume compared with placebo. 40, 45 Studies of prophylactic glucocorticoids for the prevention of hypotension have also shown improved blood pressures and reduced need for vasopressors. 33, 43, 46, 47 In the largest study, 360 intubated ELBW infants were randomized to receive either prophylactic treatment with hydrocortisone (1 mg per kg per day) or placebo for 12 days to prevent bronchopulmonary dysplasia. Daily mean arterial pressures were significantly higher in the hydrocortisone-treated infants. 33 Evidence for relative adrenal insufficiency in term newborn infants Rationale Although suboptimal cortisol responses in the ill term newborn population may occur from the same mechanisms that cause relative adrenal insufficiency in the adult, the newborn may also be uniquely susceptible to adrenal insufficiency because of shifts in hormone production during transition to extrauterine life. 48 CRH is produced in increasing concentrations by the placenta throughout gestation, resulting in maternal and fetal serum CRH concentrations at term that are far higher than at any other time in life. 49 Like CRH from the hypothalamus, placental CRH stimulates cortisol production in the fetal adrenal gland. However, in contrast to hypothalamic CRH, which is inhibited by cortisol, placental CRH production is further stimulated by cortisol, resulting in a 'feed-forward' loop of increasing production of cortisol and CRH. 50 At birth, the very high concentration of CRH from the placenta is suddenly withdrawn. The hypothalamic production of CRH may be transiently suppressed and/or the pituitary gland may be transiently refractory to the lower concentrations of CRH produced by the hypothalamus, and may not be able to increase ACTH to stimulate the adrenal gland of the newborn infant for several days. If the newborn is well, this brief refractory period is well tolerated; however, if the infant is seriously ill, a state of relative adrenal insufficiency and cardiovascular compromise may ensue.
Although there is less information about adrenal insufficiency in the ill term newborn than in children or adults or even preterm newborns, case reports and observational studies have found suboptimal cortisol responses in the face of surgery or acute illness. Some term newborns undergoing cardiac surgery for complex congenital heart defects have very low cortisol values (<5 to 10 mcg per 100 ml) post-operatively, far lower than the values seen in adult post-operative patients. 51, 52 In another study of surgical infants, cortisol levels did not correlate with degree of stress, and the authors postulated that the poor correlation was a reflection of impaired cortisol secretion in newborn infants. 53 Investigations in critically ill term newborns have also supported the existence of relative adrenal insufficiency in this population. In 1986, Thomas et al. 54 reported that 3 of 11 ill term newborns had undetectable basal cortisol values (<1 mcg per 100 ml). Pittinger and Sawin 55 reported that 79% of 34 cortisol levels measured in 10 critically ill infants with congenital diaphragmatic hernia were <7 mg per 100 ml, and that 2 of the 4 infants who died had a low cortisol response to ACTH (<30 mcg per 100 ml). Tantavit et al. 56 reported that 6 of 7 critically ill term newborns with refractory hypotension had cortisol values of <15 mcg per 100 ml, 5 of which were <10 mcg per 100 ml and all responded to glucocorticoid administration with hemodynamic stabilization. Soliman et al. 57 recently reported that 11 of 30 septic term newborns had basal cortisol values of <15 mcg per 100 ml.
We have reported similar findings in two studies. First, in a retrospective chart review, we found that 56% of 32 ventilated infants on vasopressors had cortisol concentrations of <15 mcg per 100 ml, and that these infants responded to hydrocortisone with increased blood pressure, decreased receipt of dopamine and decreased heart rate. 58 In a subsequent prospective study, we confirmed the high prevalence of very low cortisol values in critically ill, hypotensive, late preterm and term newborn infants. 59 The median (25th to 75th percentile) baseline cortisol value in these 35 infants was 4.6 mcg per 100 ml (3.0 to 16.2), and 74% were <15 mcg per 100 ml. Values did not increase with increasing severity of illness. Interestingly, the ACTH-stimulated cortisol values in these infants reached a median of 41 mcg per 100 ml (30.3 to 51.8), similar to the median values in our non-critically ill patients (34.2 mcg per 100 ml), and to median values reported in well infants (38.1 mcg per 100 ml). 57 We also measured ACTH concentrations in a subset of these critically ill infants (n ¼ 10), and found that they were 12 pg ml À1 (5.5 to 19.2), similar to what Soliman et al. 57 found in their ill infant population (n ¼ 10, median 11.9 pg ml À1 (4.3 to 19)), far lower than the concentrations found in critically ill adults and children. 60, 61 Thus, the majority of these critically ill newborns had very low cortisol and ACTH values, without the expected increase in response to critical illness; however, their response to exogenous ACTH was normal, showing that the inadequate response to critical illness in these newborns does not result from adrenal dysfunction, and therefore must arise from another component of the HPA axis. 59 Data regarding the association of treatment of adrenal insufficiency with outcomes in the term newborn are limited, 56, 58 with no studies on outcomes beyond the immediate neonatal period. Although no adverse events have been attributed to glucocorticoid treatment, the studies to date contain very small numbers.
Should we treat relative AI in newborns?
Although low cortisol values in both preterm and term newborn infants have been associated with conditions such as hypotension, inflammation and bronchopulmonary dysplasia, there is currently insufficient evidence to support the routine use of glucocorticoids in these patients. At the same time, however, clinicians are commonly faced with critically ill infants who have cardiovascular insufficiency with hypotension, a condition that has also been associated with adverse consequences. [62] [63] [64] [65] [66] [67] Current therapy for hypotension consists primarily of volume expanders and vasopressors, which only treat the symptom. If the etiology of the hypotension in some of these infants is relative adrenal insufficiency, treatment with hydrocortisone would be more appropriate. Further study is warranted to evaluate whether hydrocortisone replacement therapy for adrenal insufficiency is a more appropriate treatment for hypotension. Although awaiting further studies, when faced with an infant with vasopressor-resistant hypotension accompanied by signs of inadequate cardiac function, the clinician might consider the following treatment.
Preterm infants
As hydrocortisone therapy given simultaneously with indomethacin or ibuprofen has been associated with the short-term outcome of spontaneous gastrointestinal perforation in extremely preterm infants, care should be taken to avoid concurrent therapy. 33, 68 In addition, infants who develop spontaneous perforation have been noted to have high endogenous cortisol concentrations. 33, 68 Data thus far are reassuring about long-term outcomes in preterm infants treated with hydrocortisone. 69, 70 If hydrocortisone therapy is being considered for the extremely preterm infant with refractory hypotension, a blood specimen for cortisol should be obtained before initiating therapy. Pending that result, a test dose of 1 mg kg À1 can be given. If the blood pressure improves within 2 to 6 h, this can be followed by 0.5 mg kg À1 every 12 h (B8 to 10 mg per m 2 per day), with the longer dosing interval because of the longer half-life of hydrocortisone in these immature infants. 71 This dosing strategy has been shown to increase serum values by an average of 5 mcg per 100 ml, whereas higher doses have been associated with very high serum concentrations. If the initial cortisol value is high (>15 to 20 mcg per 100 ml), the clinician may consider stopping the drug, especially if there has been no cardiovascular response.
Term infants
In contrast to extremely preterm infants, these infants should not be susceptible to spontaneous gastrointestinal perforation associated with intestinal immaturity. 72 If hydrocortisone is considered, a specimen should be obtained for cortisol, and a test dose of 1 mg kg À1 can be given. If the blood pressure improves within 2 to 6 h, further doses of 0.5 mg kg À1 can be given at 6-to 8-h intervals because of the likely shorter half-life for hydrocortisone in term infants, as seen in the very few infants studied. 73 For both term and preterm infants, the ideal length of therapy is unknown. In term infants, in whom relative adrenal insufficiency may be because of transition to extrauterine life, the duration of the problem should be relatively brief. The hydrocortisone can be discontinued after 48 to 72 h and the cardiovascular status of the infant monitored. Extremely preterm infants may have a longer duration of inadequate adrenal function owing to their immaturity; 74 however, this too is not known and the goal should be to minimize the length of therapy, perhaps stopping after 3 to 5 days and monitoring the cardiovascular function.
Conclusion
In summary, relative adrenal insufficiency in critical illness is a well-documented entity in other populations. Newborns have unique reasons to experience relative adrenal insufficiency, and there is growing evidence to support its existence in ill preterm and term newborns. However, until there is more information available on the best methods for diagnosis, indications, associated outcomes, effectiveness and safety of the treatment with glucocorticoids, ill newborn infants should be treated cautiously, using the lowest dose possible for the shortest amount of time.
